All 5 patients with anti-CASPR2 encephalitis were treated with a combination of intravenous methylprednisolone and IVIG, 1 of which was also treated with rituximab (14 days after the treatment of IVIG) because of poor efficacy. This evidence concerns the gene CNTNAP2 and viral encephalitis.